Overview

Gender

male

Daniel E. Geffken is the founder and managing director of Danforth Advisors, a consulting firm providing administrative, strategic and operational support to life science companies. He has more than 20 years of experience in the life science industry, with companies ranging from early startups to publicly-traded companies with over $1 billion market capitalizations. Previously, he served as chief operating officer or chief financial officer of four publicly-traded and four privately-held companies, in addition to his consulting clients, and was interim chief executive officer of a medical device company.

In these roles, he held management responsibility for finance, accounting, human resources, investor/public relations, facilities, legal, intellectual property and manufacturing functions. Mr. Geffken has raised more than $700 million in equity and debt securities, including a $132 million private placement that was, at the time, the largest private investment in public equity (PIPE) in biotechnology history.

Previous to these roles, Mr. Geffken was a principal in a private equity firm, and prior to that position was a certified public accountant (CPA) at KPMG. Mr. Geffken holds a master’s degree in business administration from Harvard Business School and a bachelor’s degree in economics from The Wharton School at the University of Pennsylvania.